Treatment of pyoderma gangrenosum with cyclosporine.

Published

Journal Article

BACKGROUND AND DESIGN: Pyoderma gangrenosum is a chronic inflammatory ulcerative skin disease of unknown origin, often associated with various diseases including inflammatory bowel disease, inflammatory arthritis, monoclonal gammopathies, hepatitis, and myeloproliferative disorders. Treatment of associated systemic disorders may improve the ulcers, but lesions may be recalcitrant and persist for months to years. Therapy for pyoderma gangrenosum includes high-dose systemic corticosteroids, sulfa drugs such as sulfasalazine, clofazimine, and immunosuppressive agents such as mercaptopurine and azathioprine; these drugs are sometimes ineffective. RESULTS: We present a series of 11 patients with pyoderma gangrenosum, with a wide range of underlying diseases, whose ulcers were refractory to usual therapy and who were treated with low-dose cyclosporine. Ten of the 11 patients cleared rapidly and completely with cyclosporine therapy. CONCLUSIONS: Cyclosporine should be seriously considered as a primary form of treatment for pyoderma gangrenosum.

Full Text

Duke Authors

Cited Authors

  • Matis, WL; Ellis, CN; Griffiths, CE; Lazarus, GS

Published Date

  • August 1992

Published In

Volume / Issue

  • 128 / 8

Start / End Page

  • 1060 - 1064

PubMed ID

  • 1497359

Pubmed Central ID

  • 1497359

International Standard Serial Number (ISSN)

  • 0003-987X

Language

  • eng

Conference Location

  • United States